PDL BIOPHARMA INC - NOTE 2.750%12/0

CUSIP: 69329YAG9

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Debt / NOTE 2.750%12/0
Market price (% of par)
90.01%
Total 13F principal
$120,237,000
Principal change
-$1,380,000
Total reported market value
$108,382,000
Number of holders
16
Value change
-$360,497
Number of buys
9
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 69329YAG9?
CUSIP 69329YAG9 identifies 69329YAG9 - PDL BIOPHARMA INC - NOTE 2.750%12/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PDL BIOPHARMA INC - NOTE 2.750%12/0 as of Q2 2017

As of 30 Jun 2017, PDL BIOPHARMA INC - NOTE 2.750%12/0 was held by 16 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $120,237,000 in principal (par value) of the bond. The largest 10 bondholders included WHITEBOX ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, LAZARD ASSET MANAGEMENT LLC, ZAZOVE ASSOCIATES LLC, LINDEN ADVISORS LP, Context Capital Management, LLC, OAKTREE CAPITAL MANAGEMENT LP, DEUTSCHE BANK AG\, and CNH PARTNERS LLC. This page lists 16 institutional bondholders reporting positions for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.